Mapletree Pan Asia Commercial Trust Full Year 2025 Earnings: EPS Beats Expectations

editorial-team@simplywallst.com (Simply Wall St)

Sat, Apr 26, 2025, 6:03 PM 1 min read

Mapletree Pan Asia Commercial Trust (SGX:N2IU) Full Year 2025 Results

Key Financial Results

Revenue: S$917.7m (down 4.8% from FY 2024).
Net income: S$584.2m (up 1.1% from FY 2024).
Profit margin: 64% (up from 60% in FY 2024).
EPS: S$0.11 (up from S$0.11 in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

revenue-and-expenses-breakdown — SGX:N2IU Revenue and Expenses Breakdown April 27th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Mapletree Pan Asia Commercial Trust EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 59%.

The primary driver behind last 12 months revenue was the Singapore - Vivocity segment contributing a total revenue of S$242.2m (26% of total revenue). The most substantial expense, totaling S$57.9m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how N2IU's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 2.6% p.a. on average during the next 3 years, while revenues in the REITs industry in Asia are expected to remain flat.

Performance of the market in Singapore.

The company's shares are up 1.7% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 4 warning signs for Mapletree Pan Asia Commercial Trust (2 don't sit too well with us!) that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.